Breaking News
March 20, 2019 - Biohaven’s Verdiperstat Receives Orphan Drug Designation From FDA For Multiple System Atrophy
March 20, 2019 - Smoking may limit body’s ability to fight dangerous form of skin cancer
March 20, 2019 - Researchers receive $9.7-million grant to develop new hearing-loss treatments for deaf
March 20, 2019 - TGen and ABL sign agreement to distribute new TB test technology
March 20, 2019 - UCD researchers lead development of new urine test to detect prostate cancer
March 20, 2019 - Miniature brains that can move muscles, grown in the lab
March 20, 2019 - Servier and Oncodesign announce research and drug development partnership
March 20, 2019 - FDA warns marketer of unapproved products claiming to treat addiction, chronic pain
March 20, 2019 - TB Medicine Pretomanid Enters Regulatory Review Process in the United States
March 20, 2019 - Breastfeeding can erase effects of prenatal violence for newborns
March 20, 2019 - Tens of Thousands of Heart Patients May Not Need Open-Heart Surgery
March 20, 2019 - Space worries – shingles affecting astronauts says NASA
March 20, 2019 - Study shows how AI can improve physicians’ diagnostic accuracy
March 20, 2019 - Dolomite Bio launches new scRNA-Seq Reagent Kit at AGBT 2019
March 20, 2019 - World’s oldest semen viable for artificial insemination
March 20, 2019 - FDA Approves Zulresso (brexanolone) for the Treatment of Post-Partum Depression
March 19, 2019 - How it manipulates us to tribalism
March 19, 2019 - How can doctors encourage patients to adopt healthier behaviors?
March 19, 2019 - Meet Hal: He's One Sick Robot
March 19, 2019 - Blood test and mathematical model can estimate preterm birth rate in low-resource countries
March 19, 2019 - TAVR procedure safe in patients with unusual valve anatomy
March 19, 2019 - Proteins in the eye may be potential source for cost-effective test to predict Alzheimer’s disease
March 19, 2019 - Opioid Prescriptions Dropped for New Users From 2012 to 2017
March 19, 2019 - New method may better predict the best treatment for burn wounds
March 19, 2019 - “Asian” isn’t specific enough for health data, research suggests
March 19, 2019 - ColumbiaDoctors Presents Honors for Outstanding Commitment to Patient Safety
March 19, 2019 - Innovative model identifies primate species with potential to transmit Zika in the Americas
March 19, 2019 - One-off surgery could offer hope to patients with high blood pressure
March 19, 2019 - Many pet owners interested in feeding their pets with plant-based diet
March 19, 2019 - How to Protect Your Kids From Drowning
March 19, 2019 - CEA Test: MedlinePlus Lab Test Information
March 19, 2019 - Two years after face transplant, Andy Sandness’ smile shows his progress
March 19, 2019 - Registration now open for Stanford’s Big Data in Precision Health conference
March 19, 2019 - Gene Keeps Fear at Bay, But Only in Females
March 19, 2019 - Cholesterol lowering drug can also help treat cancer-associated cachexia
March 19, 2019 - GARDP and Evotec partner to tackle growing threat of antimicrobial resistance
March 19, 2019 - Ultrasound offers precise, minimally invasive way to measure cardiac output in children
March 19, 2019 - Study suggests potential new approach to treat atopic dermatitis
March 19, 2019 - Sense of control over life makes older adults feel younger
March 19, 2019 - Study shows how probiotics influence gut microbiota
March 19, 2019 - Study offers new evidence that narcolepsy is an autoimmune condition
March 19, 2019 - Breastfeeding may offer long-term heart health benefits for women
March 19, 2019 - Study of young athletes suggests snoring and sleep apnea are linked to sudden cardiac death
March 19, 2019 - Did Your Doctor ‘Ghost’ You? An Employment Contract May Be To Blame
March 19, 2019 - Food pantry clients more likely to make healthy choices when meal kits and recipe tastings are available
March 19, 2019 - Mental health problems among children increasing
March 19, 2019 - New ISO standard helps evaluate and manage impact of environmental damage
March 19, 2019 - CardioMEMS heart failure sensor reliably safe, effectively reduces hospitalizations
March 19, 2019 - Researchers report promising results of potential reversal agent
March 19, 2019 - Scientists identify brain circuit responsible for cocaine-seeking behavior during relapse
March 19, 2019 - First African-American Neuroscience Research Initiative launched to close the gap in health disparities
March 19, 2019 - Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study
March 19, 2019 - Attitudes about health affect how older adults engage with negative health news
March 19, 2019 - Huron Digital Pathology to unveil new ‘Scan Index Search’ platform at USCAP 2019
March 19, 2019 - Frequent intake of sugary drinks tied to greater risk of premature death
March 19, 2019 - Bruker showcases new analytical systems and applied market solutions at Pittcon 2019
March 19, 2019 - Framingham cardiovascular risk prediction model from the 1990s still gives the best results
March 19, 2019 - New article focuses on integrative health, value-based medicine, and whole systems research
March 19, 2019 - Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
March 19, 2019 - National survey of emergency dept management of self-harm highlights successes, room for improvement
March 19, 2019 - Scientists reverse alcohol-seeking behavior in rats with flip of a switch
March 19, 2019 - Researchers hope blood test that accurately diagnoses fibromyalgia could be available within five years
March 19, 2019 - New Planmeca ProScanner 2.0 offers fast and dependable intraoral imaging
March 19, 2019 - A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke
March 19, 2019 - Common medications to treat heartburn linked to increased risks for kidney failure
March 19, 2019 - Current HBV genome sequences help deduce ancient human population movements into Australia
March 19, 2019 - Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events
March 19, 2019 - Researchers use big data to gain better understanding of hepatitis E virus
March 19, 2019 - Use of synthetic psychedelic linked to improvements in depression and anxiety
March 19, 2019 - GARP protein can be a potential target for immunotherapy against colorectal cancer
March 19, 2019 - Knee Pain Not Tied to Activity Levels in Knee Osteoarthritis
March 19, 2019 - Study shows benefits of delayed cord clamping in healthy babies
March 19, 2019 - Pharmacists can undertake overall clinical responsibility for patients, shows study
March 19, 2019 - A cell’s “self-destruct” function could yield new therapies
March 19, 2019 - Latest advances and perspectives of all AI types used in pharmaceutical R&D
March 19, 2019 - Prophylactic cranial irradiation used as standard approach for patients with NSCLC
March 19, 2019 - Sugar-sweetened beverages may be linked with increased risk of cardiovascular mortality
March 19, 2019 - AHA News: Black Woman in Their 50s Face Especially High Stroke Risk
March 19, 2019 - Secrets of early life revealed from less than half a teaspoon of blood
March 19, 2019 - Immune cells engineered to tattle on suspicious cells in the body
UA researchers discover promising lead in genetic approach to treating deadly brain cancer

UA researchers discover promising lead in genetic approach to treating deadly brain cancer

image_pdfDownload PDFimage_print

Glioblastoma, a deadly brain cancer that has grabbed headlines for claiming the lives of Sens. Edward Kennedy and John McCain, could be “tricked” into sparing more of its victims.

A team of University of Arizona researchers who looked for genetic differences between glioblastoma cells from long- and short-term survivors discovered that those who survived longer had a protein that might be targeted to increase survival in all glioblastoma patients. The results were presented this month at the Society for Neuro-Oncology conference in New Orleans. This work is in its early stages, and the researchers say they are many years and millions of dollars away from potential translation into treatments for patients.

“Glioblastoma essentially is incurable,” said Baldassarre “Dino” Stea, MD, PhD, head of the UA College of Medicine – Tucson Department of Radiation Oncology. “In the past 15 years, only one drug — temozolomide — has been invented, whereas the rest of the cancer field is zooming forward.”

With surgery, followed by chemotherapy and radiation, adults with glioblastoma survive for an average of 11-15 months. Some succumb sooner, while others outlive their initial prognosis by months or even years.

“I was curious to know how genes are differentially expressed in patients who live longer,” said Michael Hammer, PhD, co-director of the UA Cancer Center Genomics Shared Resource and research scientist with the UA BIO5 Institute. “If we can identify a pathway in the tumor that we might be able to target, we can try to make the short-lived patients look more like the long-lived patients.”

Drs. Stea and Hammer helped discover that long-term survivors manufacture a protein called WIF-1 in relative abundance. The team first searched for “signaling pathways,” a collection of genes that control cellular function under normal circumstances but can go awry to cause cancer.

“The Wnt signaling pathway popped up as the most important pathway to limit the survival chances of glioblastoma patients,” Dr. Hammer said. This pathway normally is involved with tissue maintenance but can fuel tumor growth if it becomes overactive. Long-term survivors appeared to rely on genes that suppress the function of the Wnt signaling pathway.

“We had a pile of genes and looked for an overrepresentation of these genes compared to a random set of genes,” Dr. Hammer said. “We found that, in patients who survived longer than average, certain genes were tamping down Wnt signaling.”

After sifting through 800 genes in 23 glioblastoma samples, the team identified the WIF-1 gene, which manufactures the WIF-1 protein, as an important inhibitor of the Wnt pathway and a strong predictor of long-term survival.

“The Wnt pathway is deranged, and WIF-1 is the police. Cancer grows when there aren’t enough police to keep the deranged person in check,” Dr. Stea said. “Some people are endowed with more WIF-1 and survive longer.”

While testing for the WIF-1 gene someday may help oncologists predict which patients will survive longer, a greater hope is that this work will lead to a drug that targets glioblastoma tumors with more precision than standard treatment.

“We hope to create a drug to suppress the Wnt pathway so that everybody survives longer,” Dr. Stea said. “It would be the pot of gold at the end of the rainbow.”

Dr. Stea believes new approaches are essential to extend survival for glioblastoma patients.

“I think we have reached the apex of what the surgeon can do, and have achieved the most we can with radiation,” he said. “The cure will not come from more radiation or more surgery — glioblastoma is a genetic problem that we have to solve genetically.”

One way to enlist human genetics in the fight against glioblastoma is to enhance the effects of radiation, which kills cancer cells by damaging their DNA. Glioblastomas have a special ability to repair this DNA damage, diminishing radiation’s effectiveness.

“I’m poking holes in the DNA of glioblastoma cells, and the Wnt pathway goes back and helps to repair the damage,” Dr. Stea said, referring to his work as a radiation oncologist. “It’s like I’m exploding a bridge so the enemy cannot cross, but overnight they rebuild the bridge.”

By taking cues from WIF-1, scientists might be able to weaken glioblastoma’s ability to repair radiation-damaged DNA.

“The Wnt pathway activates DNA repair. If we can suppress Wnt, we also suppress DNA repair. When we mimic that in the lab by adding WIF-1 protein to glioblastoma cells, they become more sensitive to radiation,” said Eric Weterings, PhD, assistant professor at the UA College of Medicine – Tucson Department of Radiation Oncology, who also contributed to the study.

“Right now, I can only give so much radiation. If we exceed that threshold, we’re more likely to damage the brain,” Dr. Stea added. “We have a hint that WIF-1 can help radiation do a better job, compounding its cancer-killing effect.”

This preliminary research was fueled in part by a gift from one of Dr. Stea’s glioblastoma patients, who is a long-term survivor at three-and-a-half years. He hoped researchers could learn from long-lived patients like himself. Many times, grateful patients help fund UA Cancer Center research.

“He is happy to be alive and very generous, so he made a gift,” Dr. Stea said. “That’s how the program got going.”

To expand upon their findings, the team currently is applying for grants to continue their research.

“We didn’t have a huge sample population, so these results could be a fluke — but they are statistically significant,” Dr. Stea said. “The next step is to validate with hundreds of patients and then to perform further studies with inhibitors of the Wnt pathway.”

“It’s a step forward,” Dr. Weterings added. “In the future, this work might give us a larger and yet more specific arsenal of options to treat this disease.”

The team already is collaborating with Tech Launch Arizona, filing a provisional patent application on the gene signature for a companion diagnostic and possible radiation sensitizer.

Source:

https://opa.uahs.arizona.edu/newsroom/news/2018/ua-team-uncovers-promising-lead-genetic-approach-treating-glioblastoma

About author

Related Articles